Neumora Therapeutics, Inc. (NMRA)

0.4832 +0.06 (+13.16%) USD  |  NASDAQ  |  Oct 16, 16:00
0.4989 +0.02 (+3.25%) After-Hours: 20:00
More

Neumora Therapeutics Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for NMRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Total Operating Expenses (% of Quarterly Revenues) Data

View and export this data back to . Start Trial.
Date Value

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
BioAge Labs, Inc. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Veru, Inc. --
Johnson & Johnson Upgrade